Timing of Immunoreactive B-Type Natriuretic Peptide Levels and Treatment Delay in Acute Decompensated Heart Failure
Alan S. Maisel(San Francisco VA Medical Center), Roger M. Mills(Janssen (Belgium)), N. McMullin(Cleveland Clinic), W. Frank Peacock(Hennepin Healthcare Research Institute), Robert Jessie(Virginia Commonwealth University Medical Center), Gregg C. Fonarow(UCLA Medical Center), Janet Wynne(Scion)
Cited by 206
Related Papers
Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction
|Circulation|2010|4.8k
Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)
|American Heart Journal|2005|2.1k
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
|Circulation|2006|2.1k
The Global Health and Economic Burden of Hospitalizations for Heart Failure
|Journal of the American College of Cardiology|2014|2k
Medical Therapy for Heart Failure With Reduced Ejection Fraction
|Journal of the American College of Cardiology|2018|1.3k